Zoetis ZTS
Zoetis is the world's largest animal health company, dedicated to the discovery, development, and commercialization of medicines, vaccines, and diagnostics for companion and production animals. Zoetis maintains a solid competitive moat with a 64.91% ROE and a 40.72% operating margin, but growth has stalled (revenue -0.2%) and momentum is very negative (2nd percentile in 52 weeks), warranting caution despite a P/E of 11.59.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Zoetis is the world's largest animal health company, dedicated to the discovery, development, and commercialization of medicines, vaccines, and diagnostics for companion and production animals. Zoetis maintains a solid competitive moat with a 64.91% ROE and a 40.72% operating margin, but growth has stalled (revenue -0.2%) and momentum is very negative (2nd percentile in 52 weeks), warranting caution despite a P/E of 11.59.
Score by category
| Category | Score |
|---|---|
| Financial health | 8.0 |
| Quality / Moat | 8.7 |
| Valuation | 6.7 |
| Growth | 4.1 |
| Dividend | 7.3 |
| Momentum | 0.3 |
| Risk & Context | 7.6 |
OVERALL SCORE: 6.7/10
Context and risks
No material exposure to current macro factors (rates, oil, geopolitics). The animal health business is defensive and does not depend on commodities or shipping routes.
News considered in the analysis
- Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note — Titular genérico de movimiento de mercado sin información nueva sobre la compañía.
- 'Big Short' Michael Burry Tunes Out AI ‘Woo-Hoos’ — Finds Opportunity In Copper, QXO And 3 More Stocks — Mención de la acción en una lista de inversiones de un gestor famoso; sin impacto directo en fundamentales.
- 1 Mid-Cap Stock with Exciting Potential and 2 We Turn Down — Listículo con opiniones de analistas sin información concreta sobre Zoetis.
- Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note — Titular genérico de movimiento de mercado sin información nueva sobre la compañía.
- Zoetis (ZTS) Stock Fair Value Falls After Mixed Analyst Cuts And Softer Growth Views — Recortes mixtos de analistas y perspectivas de crecimiento más suaves; refleja la desaceleración ya visible en los datos.
Verdict: Hold; the quality is undeniable but the lack of growth and poor momentum suggest waiting for an improvement in figures before taking a position.
Main risk: Stagnant revenue growth (-0.2%) and weak earnings growth (1.2%) in an increasingly competitive animal health environment, which could prolong the stock's poor momentum.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →